NASDAQ:PRVB
Delisted
Provention Bio Inc. Stock News
$24.98
+0 (+0%)
At Close: Jul 24, 2023
2 Under-the-Radar Biotech Stocks to Buy in 2022
10:53am, Friday, 12'th Aug 2022
It's been a wild 12 months for these companies.
Provention Bio, Inc. (PRVB) CEO Ashleigh Palmer on Q2 2022 Results - Earnings Call Transcript
01:32pm, Saturday, 06'th Aug 2022
Provention Bio, Inc. (NASDAQ:PRVB ) Q2 2022 Earnings Conference Call August 4, 2022 8:00 AM ET Company Participants Robert Doody - Vice President, Investor Relations Thierry Chauche - Chief Financial
Provention Bio, Inc. (PRVB) Reports Q2 Loss, Lags Revenue Estimates
02:25pm, Thursday, 04'th Aug 2022 Zacks Investment Research
Provention Bio, Inc. (PRVB) delivered earnings and revenue surprises of 6.12% and 6.75%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Provention Bio, Inc. (PRVB) Reports Q2 Loss, Lags Revenue Estimates
12:02pm, Thursday, 04'th Aug 2022
Provention Bio, Inc. (PRVB) delivered earnings and revenue surprises of 6.12% and 6.75%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Provention Bio to Report Second Quarter 2022 Financial Results on August 4, 2022
07:30am, Thursday, 28'th Jul 2022
RED BANK, N.J. , July 28, 2022 /PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today announced that i
This Stock Could Soar by Nearly 300%, Says Wall Street
02:07pm, Tuesday, 26'th Jul 2022 The Motley Fool
Are the Street's predictions too optimistic?
This Stock Could Soar by Nearly 300%, Says Wall Street
10:07am, Tuesday, 26'th Jul 2022
Are the Street's predictions too optimistic?
Get in front of these three stock market sectors before they blossom into mainstream darlings
04:43pm, Friday, 22'nd Jul 2022 MarketWatch
Onshoring, outer space and biotech will be as popular as apps, streaming and crypto are today.
Accolade Shares Jump Around 29%, Here's 75 Biggest Movers From Friday
08:35am, Tuesday, 05'th Jul 2022 Benzinga
Gainers
Omeros Corporation (NASDAQ: OMER) jumped 68.7% to close at $4.64.
Clovis Oncology, Inc. (NASDAQ: CLVS) gained 58.3% to settle at $2.85 on Friday.
Fast Radius, Inc. (NASDAQ: FSRD) jumped 41.2
Provention Bio to Present at the Jefferies Global Healthcare Conference
07:30am, Friday, 03'rd Jun 2022
RED BANK, N.J. , June 3, 2022 /PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today announced that ma
2 High-Risk, High-Reward Stocks for Contrarian Investors
03:23pm, Thursday, 19'th May 2022 The Motley Fool
Feeling adventurous?
2 High-Risk, High-Reward Stocks for Contrarian Investors
11:23am, Thursday, 19'th May 2022
Feeling adventurous?
Provention Bio, Inc. (PRVB) Reports Q1 Loss, Lags Revenue Estimates
12:25pm, Thursday, 05'th May 2022 Zacks Investment Research
Provention Bio, Inc. (PRVB) delivered earnings and revenue surprises of 22.22% and 20.87%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Provention Bio, Inc. (PRVB) CEO Ashleigh Palmer on Q1 2022 Results - Earnings Call Transcript
12:11pm, Thursday, 05'th May 2022
Provention Bio, Inc. (NASDAQ:PRVB ) Q1 2022 Earnings Conference Call May 5, 2022 8:00 AM ET Company Participants Ashleigh Palmer – Co-Founder, President, Chief Executive Officer Francisco Leon – C
Provention Bio, Inc. (PRVB) Reports Q1 Loss, Lags Revenue Estimates
09:47am, Thursday, 05'th May 2022
Provention Bio, Inc. (PRVB) delivered earnings and revenue surprises of 22.22% and 20.87%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
